Oxford Vaccine Group
Oxford Vaccine Group logo
|
|
| Formation | 1994 |
|---|---|
| Purpose | Research and clinical trials |
| Location |
|
|
Director
|
Professor Andrew J Pollard |
|
Parent organization
|
University of Oxford |
| Affiliations | UKCRC registered |
|
Staff
|
75 |
| Website | www |
The Oxford Vaccine Group (OVG) is a vaccine research group within the Department of Paediatrics at the University of Oxford. It was founded in 1994 by Professor E. Richard Moxon, was initially based at the John Radcliffe Hospital, and moved in 2003 to its current location in the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) at the Churchill Hospital in Oxford, England. The group, led by Professor Andrew Pollard since 2001, comprises around 75 members across a number of disciplines, including consultants in paediatrics and vaccinology, clinical research fellows, research nurses, statisticians, post-doctoral laboratory scientists, research assistants and DPhil students.
OVG carries out research on vaccines to improve human health. It works to enhance the understanding of immunity, studies the epidemiology of infectious diseases, and conducts clinical trials into new and improved vaccines for children and adults. Research by Richard Moxon into the public health impact of Haemophilus influenzae type b (Hib) invasive disease in the UK, and efficacy studies of the Hib conjugate vaccine in UK children, led to the founding of OVG in 1994. Since then OVG has particularly specialised in research into meningococcal disease and vaccines to prevent the disease. OVG has been involved with the development of the new vaccine against MenB which was licensed in Europe in 2013. The Group has also carried out research on pneumococcal vaccines, typhoid vaccines and, more recently, new vaccines against Ebola. OVG is a research group within the Department of Paediatrics at the University of Oxford. It is a UK Clinical Research Collaboration (UKCRC) registered clinical trials unit working in collaboration with the Primary Care Unit Clinical Trials Unit (Nuffield Department of Primary Care Health Sciences) and the Jenner Institute at the University of Oxford. It is also a participant in the UK Paediatric Vaccine Group (UKPVG) and contributes to the Oxford University Hospitals NHS Trust’s tertiary Paediatric Infectious Disease and Immunology Service. All OVG trials are listed on the UK Clinical Trials Gateway. OVG supports the All Trials Campaign.
...
Wikipedia